Evaluating Safety and Tolerability of Zanubrutinib Use: Clinical Trial Perspectives
Targeted therapies, which have become mainstay of the treatment of B-cell malignancies, can have significant safety concerns especially when given for prolonged periods. Adverse events associated with BTK inhibitors, which…